FDA Inspections of Foreign Drug Manufacturers Haven’t Bounced Back After Pandemic

MedPage Today) — The FDA hasn’t recovered from its pause in foreign drug manufacturer inspections during the COVID-19 pandemic, with inspections in 2022 remaining “well below” pre-pandemic surveillance levels, a study found.
Researchers tracking…
Read More